Thomas R. Carper sold Intellia Therapeutics Inc (NASDAQ: NTLA)
Thomas R. Carper (D-DE), a U.S. Senator, has disclosed 3 trades in Intellia Therapeutics Inc (NTLA) since 2020, 2 purchases and 1 sale, worth an estimated $24K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Thomas R. Carper sold $1,001 - $15,000 of Intellia Therapeutics Inc (NASDAQ: NTLA) on August 25, 2023. Since that trade, NTLA is down -71.76% against the S&P 500 up +71.66%, an outperformance of -143.42%.
Across these filings, Thomas R. Carper has been a net buyer of NTLA (a buy-to-sell ratio of 2.00). Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
Thomas R. Carper's NTLA trades vs the price
NTLA is down -71.76% since Thomas R. Carper sold on August 25, 2023, versus +71.66% for the S&P 500.
Performance since this trade
All Thomas R. Carper NTLA trades
Thomas R. Carper & NTLA trading FAQ
Is it legal for Thomas R. Carper to trade Intellia Therapeutics Inc (NTLA) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Intellia Therapeutics Inc (NTLA), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Thomas R. Carper sell NTLA?
Thomas R. Carper disclosed a sale of $1,001 - $15,000 of Intellia Therapeutics Inc (NTLA) on August 25, 2023, according to public STOCK Act filings.
How has NTLA performed since Thomas R. Carper's trade?
Since Thomas R. Carper sold NTLA on August 25, 2023, the stock is down -71.76%, versus +71.66% for the S&P 500 over the same period, an outperformance of -143.42%.
How many times has Thomas R. Carper traded NTLA?
Thomas R. Carper has disclosed 3 NTLA trades since 2020 (2 purchases and 1 sale). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional NTLA trades?
Quantellect tracks every disclosed congressional trade in Intellia Therapeutics Inc (NTLA) on the Intellia Therapeutics Inc congressional trading page, which aggregates filings across all members of Congress.
Thomas R. Carper's NTLA tradesAll congressional filings for Intellia Therapeutics IncThomas R. Carper's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.